---
title: "Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=421539"
source_layer: us_cdc_mmwr
category: case_series
date: 2021-05-06
confidence: 高
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.

## 詳細內容

Nearly 8 million doses of the Janssen COVID-19 vaccine had been administered. Review of safety monitoring data found that 97% of reported reactions after vaccine receipt were nonserious, consistent with preauthorization clinical trials data. A total of 17 thrombotic events with thrombocytopenia were detected, including three non-CVST events.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:14:00Z*
*資料來源: CDC MMWR*
